RxDoctor Payments Data

Adam Grant, DO

Family Medicine · Little Rock, ARNPI 1487074639

Payments from drug & device makers

$7,460in general payments, 2019–2025

Across 440 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Pfizer$811
  • Novo Nordisk$636
  • Lilly USA, LLC$571
  • Amgen$527
  • plus $3K from 32 others

What the payments were for

  • Food & beverage$7,460100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,460 in reported general payments places this provider in the 90th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$43,406
Medicare patients
138
Services billed
933

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$42,987
FarxigaDapagliflozin Propanediol38$23,302
JardianceEmpagliflozin17$20,204
TrulicityDulaglutide16$17,070
EliquisApixaban15$15,820
MounjaroTirzepatide14$15,780
JanuviaSitagliptin Phosphate18$15,394
XareltoRivaroxaban19$13,853
Tresiba Flextouch U-100Insulin Degludec23$13,350
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,140
MyrbetriqMirabegron14$6,561
GemtesaVibegron12$5,484
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$4,094
Aripiprazole20$3,494
Gabapentin133$2,293

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$636$42,98736 claims
Lilly USA, LLCTrulicity, Mounjaro$571$32,85030 claims
AstraZenecaFarxiga$1,144$23,30238 claims
Boehringer IngelheimJardiance$71$20,20417 claims
PfizerEliquis$811$15,82015 claims
MerckJanuvia$71$15,39418 claims
Johnson & JohnsonXarelto$77$13,85319 claims
GSKTrelegy Ellipta$231$10,14015 claims
Astellas Pharma US IncMyrbetriq$133$6,56114 claims
Sumitomo Pharma America, Inc.Gemtesa$16$5,48412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →